NO931040L - Indol- og indazolderivater, fremgangsmaate til fremstilling og anvendelse derav - Google Patents

Indol- og indazolderivater, fremgangsmaate til fremstilling og anvendelse derav

Info

Publication number
NO931040L
NO931040L NO93931040A NO931040A NO931040L NO 931040 L NO931040 L NO 931040L NO 93931040 A NO93931040 A NO 93931040A NO 931040 A NO931040 A NO 931040A NO 931040 L NO931040 L NO 931040L
Authority
NO
Norway
Prior art keywords
indoles
preparing
procedure
indazol
derivatives
Prior art date
Application number
NO93931040A
Other languages
English (en)
Norwegian (no)
Other versions
NO931040D0 (no
Inventor
Shunji Naruto
Yuichi Sugano
Yoshiki Matsui
Toshiyuki Tonohiro
Tsugio Kaneko
Nobuyoshi Iwata
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NO931040D0 publication Critical patent/NO931040D0/no
Publication of NO931040L publication Critical patent/NO931040L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO93931040A 1992-03-23 1993-03-23 Indol- og indazolderivater, fremgangsmaate til fremstilling og anvendelse derav NO931040L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP6532392 1992-03-23
JP915693 1993-01-22

Publications (2)

Publication Number Publication Date
NO931040D0 NO931040D0 (no) 1993-03-23
NO931040L true NO931040L (no) 1993-09-24

Family

ID=26343823

Family Applications (1)

Application Number Title Priority Date Filing Date
NO93931040A NO931040L (no) 1992-03-23 1993-03-23 Indol- og indazolderivater, fremgangsmaate til fremstilling og anvendelse derav

Country Status (11)

Country Link
EP (1) EP0562832A1 (fr)
KR (1) KR930019661A (fr)
CN (1) CN1081676A (fr)
AU (1) AU3537893A (fr)
CA (1) CA2092112A1 (fr)
CZ (1) CZ47393A3 (fr)
FI (1) FI931291A (fr)
HU (1) HU9300828D0 (fr)
IL (1) IL105139A0 (fr)
NO (1) NO931040L (fr)
TW (1) TW226019B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW263504B (fr) * 1991-10-03 1995-11-21 Pfizer
IT1271352B (it) * 1993-04-08 1997-05-27 Boehringer Ingelheim Italia Derivati dell'indolo utili nel trattamento dei disturbi del sistema nervoso centrale
GB9310582D0 (en) * 1993-05-22 1993-07-07 Smithkline Beecham Plc Pharmaceuticals
US5620973A (en) * 1993-11-30 1997-04-15 Takeda Chemical Industries, Ltd. Tetracyclic condensed heterocyclic compounds and their use
ES2098186B1 (es) * 1995-02-09 1998-02-01 Consejo Superior Investigacion Composiciones farmaceuticas a base de aminometilindoles para su aplicacion terapeutica como neuroprotectores en las enfermedades de parkinson y alzheimer.
GB2308362A (en) * 1995-12-19 1997-06-25 Lilly Industries Ltd Pharmaceutical indole derivatives
US6534496B1 (en) 1997-04-17 2003-03-18 Takeda Chemical Industries, Inc. Thermogenic composition and benzazepine thermogenics
KR100648869B1 (ko) 1998-09-30 2007-02-28 다케다 야쿠힌 고교 가부시키가이샤 방광 배출력 개선제
CN1317276C (zh) * 2000-09-29 2007-05-23 中国科学院上海药物研究所 一类吲哚基哌啶类化合物及其制备方法和用途
US7132547B2 (en) 2001-12-28 2006-11-07 Takeda Pharmaceutical Company Limited Preventives/remedies for urinary disturbance
TW200621237A (en) 2004-11-01 2006-07-01 Wyeth Corp [(1-h-indazol-3-yl)methyl]phenols and (hydroxyphenyl)(1h-indazol-3-yl)methanones
BRPI0518693A2 (pt) 2004-11-29 2008-12-02 Warner Lambert Co pirazol [3,4-b]piridinas e indazàis terapÊuticos, bem como composiÇço farmacÊutica e uso dos mesmos
KR20080114688A (ko) 2006-01-13 2008-12-31 와이어쓰 5-히드록시트립타민 수용체에 대한 리간드로서의 술포닐 치환된 1ｈ-인돌
AU2011210765A1 (en) 2010-01-28 2012-09-13 President And Fellows Of Harvard College Compositions and methods for enhancing proteasome activity
JP2013526542A (ja) 2010-05-12 2013-06-24 アッヴィ・インコーポレイテッド キナーゼのインダゾール阻害薬
ES2724531T3 (es) 2011-05-12 2019-09-11 Proteostasis Therapeutics Inc Reguladores de proteostasis
WO2014116228A1 (fr) 2013-01-25 2014-07-31 President And Fellows Of Harvard College Inhibiteurs de l'usp14 utilisables en vue du traitement ou de la prévention d'infections virales
WO2015073528A1 (fr) 2013-11-12 2015-05-21 Proteostasis Therapeutics, Inc. Composés renforçant l'activité des protéasomes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2334358A1 (fr) * 1975-12-12 1977-07-08 Sogeras Nouveaux medicaments derives de l'indole
FR2477544A1 (fr) * 1980-03-07 1981-09-11 Pharmindustrie Nouveaux derives de la chloro-3 quinoleine, procedes pour leur preparation, et leur utilisation comme medicaments

Also Published As

Publication number Publication date
EP0562832A1 (fr) 1993-09-29
NO931040D0 (no) 1993-03-23
AU3537893A (en) 1993-09-30
CA2092112A1 (fr) 1993-09-24
FI931291A (fi) 1993-09-24
HU9300828D0 (en) 1993-06-28
FI931291A0 (fi) 1993-03-23
KR930019661A (ko) 1993-10-18
CN1081676A (zh) 1994-02-09
CZ47393A3 (en) 1993-11-17
TW226019B (fr) 1994-07-01
IL105139A0 (en) 1993-07-08

Similar Documents

Publication Publication Date Title
NO931040L (no) Indol- og indazolderivater, fremgangsmaate til fremstilling og anvendelse derav
NO892083D0 (no) Fremgangsmaate for fremstilling av arylmetylenyl-derivaterav tiazolidinoner, imidazolidinoner og oksazolidinoner.
NO911020D0 (no) Fremgangsmaate og preparat for koiontoforese.
NO943031L (no) Fremgangsmåte og system for understöttende kommunikasjon
DK297089D0 (da) Pyrimidinderivater og fremgangsmaade til fremstilling deraf
NO932662D0 (no) Fremgangsmaate for fremstilling av kitin og kitosan av biomedisinsk kvalitet
IS4244A (is) Aðferð til framleiðslu á Indoline afleiðum og notkun þeirra
NO891866D0 (no) Kromanderivater og fremgangsmaate for fremstilling derav.
DK0635004T3 (da) 4-Diphenylmethylpiperidinderivater og fremgangsmåde til fremstilling deraf
IS4907A (is) Nýjar bensímídasólafleiður sem vinna gegn magasári, aðferðir til að útbúa þær og lyfjablöndur sem innihalda þær
DK69989A (da) Benzodioxolderivater og fremgangsmaade til fremstilling deraf
NO892494D0 (no) Kromanderivater og fremgangsmaate for fremstilling derav.
NO932282D0 (no) Oljeaktig preparat og fremgangsmaate for fremstilling av dette
DK1693D0 (da) Pyranobenzoxadiazolderivat og fremgangsmaade til fremstilling deraf
NO894103D0 (no) Kromanderivater og fremgangsmaate for fremstilling derav.
DK530689D0 (da) Adenylcyclasederivater, fremgangsmaade til fremstilling deraf og deres anvendelse
DK0701554T3 (da) Benzisoselen-azolinderivater og -azinderivater, fremgangsmåde til fremstilling heraf og deres terapeutiske anvendelse
NO940130D0 (no) Benzimidazolderivater, fremgangsmaate for deres fremstilling og te rapeutisk anvendelse derav
NO930796D0 (no) Glykopeptidderivater, fremgangsmaate for deres fremstilling og farmasoeytiske midler inneholdende disse
DK103889D0 (da) Benzimidazooe1,2-caachinazoliner og fremgangsmaade til fremstilling heraf
NO934227D0 (no) Pyrrolderivater, fremgangsm}te for deres fremstilling og terapeutiske anvendelse
NO891630D0 (no) Fremgangsmaate og anordning for fremstilling av diafragmer.
DK291188D0 (da) 5-methoxyalkylammonium-tetrahydrofuran- og -tetrahydrothiophen-derivater, fremgangsmaade til fremstilling deraf og laegemidler indeholdende saadanne derivater
NO893963D0 (no) 3-aryloksymetyl-cefalosporinderivater og fremgangsmaate til fremstilling derav.
DK0794184T3 (da) 6-Methoxy-1H-benzotriazol-5-carboxamidderivater, fremgangsmåde til fremstilling deraf og lægemidler indeholdende dem